呼吸器疾患治療薬の世界市場インサイト、2028年までの予測Global Respiratory Disorders Drugs Market Insights, Forecast to 2028 市場の分析と洞察。呼吸器疾患用薬剤の世界市場 呼吸器疾患治療薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間にCAGR(年平均成長率)%で推移す... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。呼吸器疾患用薬剤の世界市場呼吸器疾患治療薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間にCAGR(年平均成長率)%で推移すると予想されています。 この健康危機による経済変化を十分に考慮し、2021年に呼吸器疾患薬の世界市場の%を占めた経口は、2028年までに100万米ドルの値を示し、COVID-19後の期間に改訂された%のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して%CAGRに変更されています。 中国の呼吸器障害治療薬の市場規模は2021年に100万米ドル、北米と欧州の呼吸器障害治療薬はそれぞれ100万米ドル、100万米ドルとされています。北米の割合は2021年に%、中国と欧州はそれぞれ%、%で、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%となっています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの呼吸器疾患治療薬の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%です。 本レポートは、業界標準の分析精度と高いデータ整合性により、世界の呼吸器疾患治療薬市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得できるよう支援する素晴らしい試みを行っています。本レポートの購入者は、世界の呼吸器疾患治療薬市場の全体規模(売上高)を含む、検証済みで信頼できる市場予測にアクセスすることができます。 全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の呼吸器疾患治療薬市場における持続的な成功を確実にするために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されています。本レポートを執筆したアナリストは、世界の呼吸器疾患薬市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。 世界の呼吸器疾患用薬剤の範囲と市場規模 呼吸器障害治療薬市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されています。呼吸器疾患薬の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。 タイプ別セグメント 経口 経鼻 注射器 用途別セグメント 病院 小売店 会社別 ノバルティス サノフィ テバ・ファーマシューティカル メルク・アンド・カンパニー 大日本住友製薬 マイラン アストラゼネカ ベーリンガーインゲルハイムインターナショナル バーテックス・ファーマシューティカルズ・インコーポレイテッド ロシュ グラクソ・スミスクライン 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア 北欧諸国 その他の欧州地域 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ラテンアメリカ メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ トルコ サウジアラビア UAE MEAの残りの地域 目次1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Nasal 1.2.4 Injectable 1.3 Market by Application 1.3.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Respiratory Disorders Drugs Market Perspective (2017-2028) 2.2 Respiratory Disorders Drugs Growth Trends by Region 2.2.1 Respiratory Disorders Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Respiratory Disorders Drugs Historic Market Size by Region (2017-2022) 2.2.3 Respiratory Disorders Drugs Forecasted Market Size by Region (2023-2028) 2.3 Respiratory Disorders Drugs Market Dynamics 2.3.1 Respiratory Disorders Drugs Industry Trends 2.3.2 Respiratory Disorders Drugs Market Drivers 2.3.3 Respiratory Disorders Drugs Market Challenges 2.3.4 Respiratory Disorders Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Respiratory Disorders Drugs Players by Revenue 3.1.1 Global Top Respiratory Disorders Drugs Players by Revenue (2017-2022) 3.1.2 Global Respiratory Disorders Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Respiratory Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Respiratory Disorders Drugs Revenue 3.4 Global Respiratory Disorders Drugs Market Concentration Ratio 3.4.1 Global Respiratory Disorders Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drugs Revenue in 2021 3.5 Respiratory Disorders Drugs Key Players Head office and Area Served 3.6 Key Players Respiratory Disorders Drugs Product Solution and Service 3.7 Date of Enter into Respiratory Disorders Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Respiratory Disorders Drugs Breakdown Data by Type 4.1 Global Respiratory Disorders Drugs Historic Market Size by Type (2017-2022) 4.2 Global Respiratory Disorders Drugs Forecasted Market Size by Type (2023-2028) 5 Respiratory Disorders Drugs Breakdown Data by Application 5.1 Global Respiratory Disorders Drugs Historic Market Size by Application (2017-2022) 5.2 Global Respiratory Disorders Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Respiratory Disorders Drugs Market Size (2017-2028) 6.2 North America Respiratory Disorders Drugs Market Size by Type 6.2.1 North America Respiratory Disorders Drugs Market Size by Type (2017-2022) 6.2.2 North America Respiratory Disorders Drugs Market Size by Type (2023-2028) 6.2.3 North America Respiratory Disorders Drugs Market Share by Type (2017-2028) 6.3 North America Respiratory Disorders Drugs Market Size by Application 6.3.1 North America Respiratory Disorders Drugs Market Size by Application (2017-2022) 6.3.2 North America Respiratory Disorders Drugs Market Size by Application (2023-2028) 6.3.3 North America Respiratory Disorders Drugs Market Share by Application (2017-2028) 6.4 North America Respiratory Disorders Drugs Market Size by Country 6.4.1 North America Respiratory Disorders Drugs Market Size by Country (2017-2022) 6.4.2 North America Respiratory Disorders Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Respiratory Disorders Drugs Market Size (2017-2028) 7.2 Europe Respiratory Disorders Drugs Market Size by Type 7.2.1 Europe Respiratory Disorders Drugs Market Size by Type (2017-2022) 7.2.2 Europe Respiratory Disorders Drugs Market Size by Type (2023-2028) 7.2.3 Europe Respiratory Disorders Drugs Market Share by Type (2017-2028) 7.3 Europe Respiratory Disorders Drugs Market Size by Application 7.3.1 Europe Respiratory Disorders Drugs Market Size by Application (2017-2022) 7.3.2 Europe Respiratory Disorders Drugs Market Size by Application (2023-2028) 7.3.3 Europe Respiratory Disorders Drugs Market Share by Application (2017-2028) 7.4 Europe Respiratory Disorders Drugs Market Size by Country 7.4.1 Europe Respiratory Disorders Drugs Market Size by Country (2017-2022) 7.4.2 Europe Respiratory Disorders Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Respiratory Disorders Drugs Market Size (2017-2028) 8.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type 8.2.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Respiratory Disorders Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Respiratory Disorders Drugs Market Size by Application 8.3.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Respiratory Disorders Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Respiratory Disorders Drugs Market Size by Region 8.4.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Respiratory Disorders Drugs Market Size (2017-2028) 9.2 Latin America Respiratory Disorders Drugs Market Size by Type 9.2.1 Latin America Respiratory Disorders Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Respiratory Disorders Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Respiratory Disorders Drugs Market Share by Type (2017-2028) 9.3 Latin America Respiratory Disorders Drugs Market Size by Application 9.3.1 Latin America Respiratory Disorders Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Respiratory Disorders Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Respiratory Disorders Drugs Market Share by Application (2017-2028) 9.4 Latin America Respiratory Disorders Drugs Market Size by Country 9.4.1 Latin America Respiratory Disorders Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Respiratory Disorders Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Respiratory Disorders Drugs Market Size (2017-2028) 10.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type 10.2.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Respiratory Disorders Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Respiratory Disorders Drugs Market Size by Application 10.3.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Respiratory Disorders Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Respiratory Disorders Drugs Market Size by Country 10.4.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Respiratory Disorders Drugs Introduction 11.1.4 Novartis Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.1.5 Novartis Recent Developments 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Respiratory Disorders Drugs Introduction 11.2.4 Sanofi Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.2.5 Sanofi Recent Developments 11.3 Teva Pharmaceutical 11.3.1 Teva Pharmaceutical Company Details 11.3.2 Teva Pharmaceutical Business Overview 11.3.3 Teva Pharmaceutical Respiratory Disorders Drugs Introduction 11.3.4 Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.3.5 Teva Pharmaceutical Recent Developments 11.4 Merck & Co. 11.4.1 Merck & Co. Company Details 11.4.2 Merck & Co. Business Overview 11.4.3 Merck & Co. Respiratory Disorders Drugs Introduction 11.4.4 Merck & Co. Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.4.5 Merck & Co. Recent Developments 11.5 Sumitomo Dainippon Pharma 11.5.1 Sumitomo Dainippon Pharma Company Details 11.5.2 Sumitomo Dainippon Pharma Business Overview 11.5.3 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Introduction 11.5.4 Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.5.5 Sumitomo Dainippon Pharma Recent Developments 11.6 Mylan 11.6.1 Mylan Company Details 11.6.2 Mylan Business Overview 11.6.3 Mylan Respiratory Disorders Drugs Introduction 11.6.4 Mylan Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.6.5 Mylan Recent Developments 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Respiratory Disorders Drugs Introduction 11.7.4 AstraZeneca Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.7.5 AstraZeneca Recent Developments 11.8 Boehringer Ingelheim International 11.8.1 Boehringer Ingelheim International Company Details 11.8.2 Boehringer Ingelheim International Business Overview 11.8.3 Boehringer Ingelheim International Respiratory Disorders Drugs Introduction 11.8.4 Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.8.5 Boehringer Ingelheim International Recent Developments 11.9 Vertex Pharmaceuticals Incorporated 11.9.1 Vertex Pharmaceuticals Incorporated Company Details 11.9.2 Vertex Pharmaceuticals Incorporated Business Overview 11.9.3 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Introduction 11.9.4 Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.9.5 Vertex Pharmaceuticals Incorporated Recent Developments 11.10 Roche 11.10.1 Roche Company Details 11.10.2 Roche Business Overview 11.10.3 Roche Respiratory Disorders Drugs Introduction 11.10.4 Roche Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.10.5 Roche Recent Developments 11.11 GlaxoSmithKline 11.11.1 GlaxoSmithKline Company Details 11.11.2 GlaxoSmithKline Business Overview 11.11.3 GlaxoSmithKline Respiratory Disorders Drugs Introduction 11.11.4 GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.11.5 GlaxoSmithKline Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
SummaryMarket Analysis and Insights: Global Respiratory Disorders Drugs Market Table of Contents1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Nasal 1.2.4 Injectable 1.3 Market by Application 1.3.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Respiratory Disorders Drugs Market Perspective (2017-2028) 2.2 Respiratory Disorders Drugs Growth Trends by Region 2.2.1 Respiratory Disorders Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Respiratory Disorders Drugs Historic Market Size by Region (2017-2022) 2.2.3 Respiratory Disorders Drugs Forecasted Market Size by Region (2023-2028) 2.3 Respiratory Disorders Drugs Market Dynamics 2.3.1 Respiratory Disorders Drugs Industry Trends 2.3.2 Respiratory Disorders Drugs Market Drivers 2.3.3 Respiratory Disorders Drugs Market Challenges 2.3.4 Respiratory Disorders Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Respiratory Disorders Drugs Players by Revenue 3.1.1 Global Top Respiratory Disorders Drugs Players by Revenue (2017-2022) 3.1.2 Global Respiratory Disorders Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Respiratory Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Respiratory Disorders Drugs Revenue 3.4 Global Respiratory Disorders Drugs Market Concentration Ratio 3.4.1 Global Respiratory Disorders Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drugs Revenue in 2021 3.5 Respiratory Disorders Drugs Key Players Head office and Area Served 3.6 Key Players Respiratory Disorders Drugs Product Solution and Service 3.7 Date of Enter into Respiratory Disorders Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Respiratory Disorders Drugs Breakdown Data by Type 4.1 Global Respiratory Disorders Drugs Historic Market Size by Type (2017-2022) 4.2 Global Respiratory Disorders Drugs Forecasted Market Size by Type (2023-2028) 5 Respiratory Disorders Drugs Breakdown Data by Application 5.1 Global Respiratory Disorders Drugs Historic Market Size by Application (2017-2022) 5.2 Global Respiratory Disorders Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Respiratory Disorders Drugs Market Size (2017-2028) 6.2 North America Respiratory Disorders Drugs Market Size by Type 6.2.1 North America Respiratory Disorders Drugs Market Size by Type (2017-2022) 6.2.2 North America Respiratory Disorders Drugs Market Size by Type (2023-2028) 6.2.3 North America Respiratory Disorders Drugs Market Share by Type (2017-2028) 6.3 North America Respiratory Disorders Drugs Market Size by Application 6.3.1 North America Respiratory Disorders Drugs Market Size by Application (2017-2022) 6.3.2 North America Respiratory Disorders Drugs Market Size by Application (2023-2028) 6.3.3 North America Respiratory Disorders Drugs Market Share by Application (2017-2028) 6.4 North America Respiratory Disorders Drugs Market Size by Country 6.4.1 North America Respiratory Disorders Drugs Market Size by Country (2017-2022) 6.4.2 North America Respiratory Disorders Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Respiratory Disorders Drugs Market Size (2017-2028) 7.2 Europe Respiratory Disorders Drugs Market Size by Type 7.2.1 Europe Respiratory Disorders Drugs Market Size by Type (2017-2022) 7.2.2 Europe Respiratory Disorders Drugs Market Size by Type (2023-2028) 7.2.3 Europe Respiratory Disorders Drugs Market Share by Type (2017-2028) 7.3 Europe Respiratory Disorders Drugs Market Size by Application 7.3.1 Europe Respiratory Disorders Drugs Market Size by Application (2017-2022) 7.3.2 Europe Respiratory Disorders Drugs Market Size by Application (2023-2028) 7.3.3 Europe Respiratory Disorders Drugs Market Share by Application (2017-2028) 7.4 Europe Respiratory Disorders Drugs Market Size by Country 7.4.1 Europe Respiratory Disorders Drugs Market Size by Country (2017-2022) 7.4.2 Europe Respiratory Disorders Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Respiratory Disorders Drugs Market Size (2017-2028) 8.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type 8.2.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Respiratory Disorders Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Respiratory Disorders Drugs Market Size by Application 8.3.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Respiratory Disorders Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Respiratory Disorders Drugs Market Size by Region 8.4.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Respiratory Disorders Drugs Market Size (2017-2028) 9.2 Latin America Respiratory Disorders Drugs Market Size by Type 9.2.1 Latin America Respiratory Disorders Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Respiratory Disorders Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Respiratory Disorders Drugs Market Share by Type (2017-2028) 9.3 Latin America Respiratory Disorders Drugs Market Size by Application 9.3.1 Latin America Respiratory Disorders Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Respiratory Disorders Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Respiratory Disorders Drugs Market Share by Application (2017-2028) 9.4 Latin America Respiratory Disorders Drugs Market Size by Country 9.4.1 Latin America Respiratory Disorders Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Respiratory Disorders Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Respiratory Disorders Drugs Market Size (2017-2028) 10.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type 10.2.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Respiratory Disorders Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Respiratory Disorders Drugs Market Size by Application 10.3.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Respiratory Disorders Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Respiratory Disorders Drugs Market Size by Country 10.4.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Respiratory Disorders Drugs Introduction 11.1.4 Novartis Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.1.5 Novartis Recent Developments 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Respiratory Disorders Drugs Introduction 11.2.4 Sanofi Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.2.5 Sanofi Recent Developments 11.3 Teva Pharmaceutical 11.3.1 Teva Pharmaceutical Company Details 11.3.2 Teva Pharmaceutical Business Overview 11.3.3 Teva Pharmaceutical Respiratory Disorders Drugs Introduction 11.3.4 Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.3.5 Teva Pharmaceutical Recent Developments 11.4 Merck & Co. 11.4.1 Merck & Co. Company Details 11.4.2 Merck & Co. Business Overview 11.4.3 Merck & Co. Respiratory Disorders Drugs Introduction 11.4.4 Merck & Co. Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.4.5 Merck & Co. Recent Developments 11.5 Sumitomo Dainippon Pharma 11.5.1 Sumitomo Dainippon Pharma Company Details 11.5.2 Sumitomo Dainippon Pharma Business Overview 11.5.3 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Introduction 11.5.4 Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.5.5 Sumitomo Dainippon Pharma Recent Developments 11.6 Mylan 11.6.1 Mylan Company Details 11.6.2 Mylan Business Overview 11.6.3 Mylan Respiratory Disorders Drugs Introduction 11.6.4 Mylan Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.6.5 Mylan Recent Developments 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Respiratory Disorders Drugs Introduction 11.7.4 AstraZeneca Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.7.5 AstraZeneca Recent Developments 11.8 Boehringer Ingelheim International 11.8.1 Boehringer Ingelheim International Company Details 11.8.2 Boehringer Ingelheim International Business Overview 11.8.3 Boehringer Ingelheim International Respiratory Disorders Drugs Introduction 11.8.4 Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.8.5 Boehringer Ingelheim International Recent Developments 11.9 Vertex Pharmaceuticals Incorporated 11.9.1 Vertex Pharmaceuticals Incorporated Company Details 11.9.2 Vertex Pharmaceuticals Incorporated Business Overview 11.9.3 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Introduction 11.9.4 Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.9.5 Vertex Pharmaceuticals Incorporated Recent Developments 11.10 Roche 11.10.1 Roche Company Details 11.10.2 Roche Business Overview 11.10.3 Roche Respiratory Disorders Drugs Introduction 11.10.4 Roche Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.10.5 Roche Recent Developments 11.11 GlaxoSmithKline 11.11.1 GlaxoSmithKline Company Details 11.11.2 GlaxoSmithKline Business Overview 11.11.3 GlaxoSmithKline Respiratory Disorders Drugs Introduction 11.11.4 GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2017-2022) 11.11.5 GlaxoSmithKline Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD(respiratory)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/07 10:27 155.63 円 167.26 円 203.27 円 |